$310 Million is the total value of PIER 88 INVESTMENT PARTNERS LLC's 187 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DT | Exit | Dynatrace Holdings LLC | $0 | – | -1,800 | -100.0% | -0.02% | – |
| SFIX | Exit | Stitch Fix Inc | $0 | – | -4,105 | -100.0% | -0.03% | – |
| TRHC | Exit | Tabula Rasa HealthCare Inc | $0 | – | -3,120 | -100.0% | -0.04% | – |
| WORK | Exit | Slack Technologies Inc | $0 | – | -5,410 | -100.0% | -0.04% | – |
| NEWR | Exit | New Relic Inc | $0 | – | -3,265 | -100.0% | -0.06% | – |
| Exit | Neurocrine Biosciences Inc 2.250000 05/15/2024convertible bonds | $0 | – | -330,000 | -100.0% | -0.14% | – | |
| PS | Exit | Pluralsight Inc | $0 | – | -27,100 | -100.0% | -0.14% | – |
| LVGO | Exit | Livongo Health Inc | $0 | – | -3,779 | -100.0% | -0.16% | – |
| BLUE | Exit | Bluebird Bio Inc | $0 | – | -12,175 | -100.0% | -0.20% | – |
| TWST | Exit | Twist Bioscience Corp | $0 | – | -14,990 | -100.0% | -0.35% | – |
| Exit | DexCom Incconvertible bonds | $0 | – | -490,000 | -100.0% | -0.38% | – | |
| Exit | NuVasive Incconvertible bonds | $0 | – | -1,340,000 | -100.0% | -0.42% | – | |
| Exit | Retrophin Incconvertible bonds | $0 | – | -2,005,000 | -100.0% | -0.52% | – | |
| IMMU | Exit | Immunomedics Inc | $0 | – | -27,023 | -100.0% | -0.70% | – |
| Exit | Benefitfocus Incconvertible bonds | $0 | – | -4,216,000 | -100.0% | -1.00% | – | |
| DHRPRA | Exit | Danaher Corppreferred stock | $0 | – | -4,623 | -100.0% | -2.07% | – |
| BSXPRA | Exit | Boston Scientific Corppreferred stock | $0 | – | -143,270 | -100.0% | -4.86% | – |
| BACPRL | Exit | Bank of America Corpconvertible preferred | $0 | – | -11,090 | -100.0% | -5.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-23
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HUBSPOT INC | 31 | Q2 2024 | 0.7% |
| MODEL N INC | 30 | Q1 2024 | 0.7% |
| MONOLITHIC PWR SYS INC | 29 | Q2 2024 | 0.8% |
| SILICON LABORATORIES INC | 29 | Q2 2024 | 0.6% |
| WELLS FARGO CO NEW PERP PFD CNV A | 27 | Q2 2024 | 5.7% |
| ETSY INC | 27 | Q2 2024 | 0.7% |
| SPLUNK INC | 27 | Q4 2023 | 0.7% |
| FARMLAND PARTNERS INC | 25 | Q2 2024 | 0.9% |
| Ultragenyx Pharmaceutical Inc | 25 | Q2 2024 | 0.4% |
| DENALI THERAPEUTICS INC | 24 | Q2 2024 | 0.4% |
View PIER 88 INVESTMENT PARTNERS LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-23 |
| 13F-HR | 2024-08-06 |
| 13F-HR | 2024-05-10 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-07 |
| 13F-HR | 2023-05-09 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-08 |
| 13F-HR | 2022-11-14 |
View PIER 88 INVESTMENT PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.